The Influence of the Vaginal Microbiome on Clinical Pregnancy in Patients Undergoing a Euploid Embryo Transfer

Recruiting now

Conditions studied: Vaginal Microbiome

In brief

Microorganisms such as bacteria live naturally on and in the bodies and are of great importance for our health. In the female body, almost 10% of all microorganisms live in the reproductive organs and especially in the vagina. Healthy bacteria in the vagina can defend against harmful bacteria and infections. However, it occasionally happens that the balance between healthy and harmful bacteria is disturbed, and it is believed that this could potentially harm pregnancy. However, there is not much evidence to prove a connection between an imbalance in bacteria and having an unsuccessful pregnancy. For this reason, the goal of our study is to determine if women with certain vaginal bacteria are more likely to experience pregnancy failures. If the investigators find this to be true, patients undergoing fertility treatment might be recommended regular tests in the future. If an imbalance in bacteria is found, doctors could provide treatment to restore a healthy vaginal environment, potentially improving the chances of a successful pregnancy.

Key facts

Study ID

NCT06643065

Run by

Fundación IVI

People needed

1573

Starts

2024-07-17

Expected to finish

2027-09-30

Last updated by the study team

2026-06-30

Who can join

Age: 18 and older, up to 50. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

• ART patients undergoing the transfer of a euploid embryo

You may not qualify if…

• Patients with a body mass index (BMI) ≥35
• Patients with uncorrected uterine malformations
• Patients with a unicornuate uterus
• Patients with a bicornuate uterus
• Patients with any type of submucosal myoma
• Patients with an intramural myoma if ≥4 cm
• Patients with severe adenomyosis (>50% of the uterine corpus affected as defined by the MUSA criteria [19])
• Patients undergoing transfer of an embryo with a morphology score <4BC (according to the Gardner \& Schoolcraft scoring system [18])
• Patients undergoing transfer of a day-7 embryo
• Patients who took antibiotics in the month prior to the embryo transfer (excluding antibiotics given following oocyte retrieval)

Where it is running

• Ginefiv Barcelona — Barcelona, Spain (enrolling)
• IVI Barcelona — Barcelona, Spain (enrolling)
• IVI Bilbao — Bilbao, Spain (enrolling)
• IVI Madrid — Madrid, Spain (enrolling)
• Ginefiv Madrid — Madrid, Spain (enrolling)
• IVI Málaga — Málaga, Spain (enrolling)
• Ginemed Sevilla — Seville, Spain (enrolling)
• IVI Valencia — Valencia, Spain (enrolling)
• IVI Vigo — Vigo, Spain (enrolling)
• IVI Zaragoza — Zaragoza, Spain (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.